Supply Chain and Logistics Speakers – We Would Like to Thank Our 2013 Speakers:

Carlo de Notaristefani is President and CEO of Global Operations at Teva Pharmaceuticals Ltd. where he is a member of Teva’s Executive Committee. He is responsible for supply chain operations and the procurement organization.

Prior to joining Teva, Carlo was a member of the Senior Management Team at Bristol-Myers Squibb and President of Technical Operations and Global Support Functions, with responsibility for the operations of the global Supply Chain, Quality and Compliance, Procurement and Information Technology for the corporation.

During his tenure at BMS, Dr. de Notaristefani led one of the most successful productivity transformation of the supply chain in the Pharma industry.

Before joining BMS, Dr. de Notaristefani held senior positions of increasing responsibility in the Global Operations and Supply Chain management areas with Aventis, Hoechst Marion Roussell and Marion Merrell Dow, based in Italy, Spain, France and the US.

Dr. de Notaristefani holds a degree of Doctor of Chemical Engineering from the University of Naples, Naples, Italy, is a registered PE, and is APICS CIRM certified.

Philippe Lambotte leads Merck's Supply Chain Management (SCM) organization with global responsibility for product planning, capacity and sourcing management, supply chain solutions and alliance management for the company's human health, vaccines and consumer care business. He also oversees Merck's worldwide distribution and logistics network that supports the company's extensive research, marketing and manufacturing activities. He is also responsible for leading the user side of the global SAP implementation at Merck.

Philippe holds a Bachelors Degree in Electrical Engineering from the University of Liege, Belgium and a Masters Degree in Electrical Engineering from the University of Southern California.

With 27 years of supply chain and manufacturing experience in the consumer goods industry, Philippe joined Merck in October 2011 from Kraft Foods, where he served as Senior Vice President, Customer Service and Logistics. In that role, Philippe oversaw a global supply chain that spanned about 170 markets, directed all worldwide strategic logistics projects and managed an organization of nearly 8,000 people.

Philippe's background includes driving efficiency cost savings while realizing industry-leading customer service levels, running a US food network sourced from 150 plants and delivering to 900 customer warehouses and 55,000 stores, and developing processes to ensure successful product delivery to markets where Kraft had no physical presence.

Previous to Kraft Foods, Philippe was working for Procter & Gamble and responsible for Manufacturing Commercialization of Disposable Products in Europe based in Germany.

Philippe extensive international experience includes working in 38 countries and living in 5 countries.

Philippe lives in Princeton, New Jersey and is married to Fatemeh with whom he raised one son currently studying BioMedical Engineering at the University of Rochester, NY and one daughter studying for her Ph.D in Marketing at University of Chicago, Illinois.

Key supply chain project you are currently working on:
Implement Global Sales and Operations Planning

What is your major investment area within the supply chain?
Information Systems – SAP implementation

What you foresee being your supply chain’s key challenge for the next 12 months, and how are you planning to overcome this?
Balance cost reduction and inventory reduction

What benefits do you plan to take home from LogiPharma?
Benchmarking of the industry & networking with peers

Dr Denis Broun has been serving as Executive Director of UNITAID since September 2011, bringing to UNITAID extensive policy dialogue and field experience, having for the past 25 years worked in public health and health economics with a large network of partners in government, civil society, private sector, foundations and international organizations.

Prior to joining UNITAID, Dr Broun was regional director of UNAIDS for Europe and Central Asia, after having been director of partnerships for UNAIDS in Geneva and UNAIDS country coordinator in India. Dr Broun’s background in the UN extends also to his time as chief of health of UNICEF in New York and as director of resource mobilization at the World Health Organization.

Dr Broun’s longstanding interest in and commitment to pharmaceutical policies and expanded access to medicines may be illustrated by his engagement as the senior specialist of the pharmaceutical sector in the World Bank, as European director of Management Sciences for Health and in his capacity as former board member of a private Indian generic company and an American Foundation working on access to medicines in Africa.

Dr Broun holds a medical degree from Paris University with specialization in tropical medicine and epidemiology. He is moreover a graduate of the Paris Institute of Political Sciences. In addition to his native French, Dr Broun speaks English, Spanish, Russian and some Hindi.

Philippe Francois is currently the Supply Chain vice president for Baxter healthcare for the Europe Middle East and Africa region He holds a master degree in engineering and an MBA and started his career in the automotive industry in France where he acquired a solid experience in Just in time techniques. He joined the healthcare industry where he has been working for the last 15 years and acquire an international experience in Europe and Asia where he had various managerial positions in the supply chain field for American and European multinationals. He is a certified black belt and has been using extensively business process improvement methodologies to shape product supply chain and drive business value for healthcare professionals. He is looking forward to share and exchange experience and ideas during the Logipharm conferences to position the supply chain as a strategic function within the pharma industry.

What you foresee being your supply chain’s key challenge for the next 12 months, and how are you planning to overcome this?
The pharma industry is facing major challenges related to the continuous pressure from the government to reduce healthcare spent, the growing regulatory constraints to register drugs and the increasing research and development delays to bring innovative treatment into the market. All these elements have a direct consequences on the capacity of the Pharma industry to maintain business growth. When product sales are slowing down, everybody is therefore focusing on service, either to sell service added value to patient or to control and reduce cost. In that context the supply chain function become more than ever strategic to either provide new solution to support customer and patient needs, or to control and improve continuity of supply.

Key supply chain project you are currently working on:
In 2013 my team and I will continue to analyze customer purchasing behavior and patients unmet needs, design and segment our service offering accordingly, integrate our operational processes to eliminate waste and focus on value and cost.

What is your major investment area within the supply chain?
Most of the investments foreseen will support process integration, end to end value stream and network optimization. We will continue to upgrade our systems, the profile of our people and develop partnership with providers.

What benefits do you plan to take home from LogiPharma? 
I come to logipharma to meet peers and exchange about experience with logistics partners, systems partners. Exchange about the best way to position the supply chain function as a strategic component of the company, meet great people and have fun.

Andy has worked in AZ for 25 years (through ICI, Zeneca and then AstraZeneca) joining originally as a Chemical Engineer and have worked across all parts of the supply chain. In his early career Andy held a variety of Engineering and Production Management roles which included working in France. More recent roles have including Global Supply Chain Manager, Engineering Manager for an API site undergoing major expansion, establishing a new logistics department on one of AZ's largest manufacturing sites and then subsequently leading it plus the Packaging Manufacturing during a major Lean transformation. Present role is the Head of Global Supply Chain Planning.

Key supply chain project you are currently working on:
Master data management, improving business intelligence and planning capability

What is your major investment area within the supply chain?
Major investments are related to master data management

What you foresee being your supply chain’s key challenge for the next 12 months, and how are you planning to overcome this?
Taking the S and OP process to the next level and working to improve the responsiveness and agility of the supply chain

What benefits do you plan to take home from LogiPharma?
Understand how others are tackling the challenges of making their supply chain more responsive, how others engage the commercial function in the S and OP process and to continue to develop my professional network

Stephen Gotthardt has been with Boehringer Ingelheim since 1999. In his current position, he is Corporate Vice President Supply Chain & Key Account Management and is based in Germany. Since 2000, Stephan has been a key member and chairperson of Boehringer Ingelheim’s worldwide supply chain organization and of its Global Supply Chain Conferences.

Key supply chain project you are currently working on:
Distribution hub concepts, risk mitigation/contingency, global replenishment planning

What is your major investment area within the supply chain?
Global process standardization

What you foresee being your supply chain’s key challenge for the next 12 months, and how are you planning to overcome this?
Innovation in distribution, business models in emerging market countries

What benefits do you plan to take home from LogiPharma?
Exchange of most burning topics across industries, networking

Hillel West is responsible for development of Operations and Supply Chain Strategy at Teva Pharmaceuticals - the world's largest supplier of generic pharmaceuticals. Teva's strategy includes the balancing of global optimisation with local accountability and a dynamic, entrepreneurial business culture. Hillel has 25 years Supply Chain experience in Pharmaceuticals and CPG, in various Supply Chain Management roles, across US, E. Europe, Australia and Israel. For 10 years, he was a director at PwC Consulting, responsible for a number of Supply Chain strategy, process, and organizational transformation engagements in US and Emerging Markets.

Key supply chain project you are currently working on:
Operations and Supply Chain risk management, Inventory optimization, Supply Chain Planning, Operations Network redesign

What is your major investment area within the supply chain?
Supply Chain Planning systems to support our new Global ERP initiative

What you foresee being your supply chain’s key challenge for the next 12 months, and how are you planning to overcome this?
Organisational and process redesign – removing some of the inherent complexity from our global supply network

Developing new advanced supply chain competencies

What benefits do plan to take home from LogiPharma?
Updated picture of SCM thinking across the industry, with a couple of new ideas for future implementation at Teva

Frédéric Bourgeois is head of Global Quality Supply Chain for Sanofi Group. He is pharmacist. He has joined the Industrial Affairs of Sanofi in 1987 as plant manager, then, distribution platform manager in France and in the US, before to become Associate Vice President, in charge of leading and coordinating the Quality, Security and Traceability of Sanofi products and materials, all along their flows.

Key Supply Chain projects you are currently working on?
Flows from suppliers to customers, traceability end to end. Transport

What is your major investment area within the Supply Chain?
Quality, Integrity and Security of the Supply Chain

What you foresee being your Supply Chain’s key challenge for the next 12 months, and how are you planning to overcome this?
To be able to anticipate the evolution of the world wide regulations, notably in terms of traceability, fight against falsification, diversion and transport.

What benefits do you plan to take home from LogiPharma?
Networking

Jyrki Syväri, Pharmacist and Chemist, made his PhD Theses in Pharmaceutical Chemistry and his Diploma in Chemistry in Analytical Chemistry. He joined Schering AG in Berlin and headed there a R&D Laboratory for the development of parenteral drugs. He left Schering AG to join Boehringer Ingelheim (corporate headquarters), where he became a Project Manager in Operations. He was responsible for the world-wide launches of new products, such as Metalyse and Spiriva. Thereafter he was heading a group called “Launch and Special Supplies”. In this function he was responsible for setting up supply chains for Boehringer Ingelheim’s new products. New Supply Chain paradigms and concepts fell also under his responsibility. In this context he became the world-wide project leader for BI’s Product Safety & Security project that centres around serialisation.

Major challenge in 2012 will be to move serialization at Boehringer Ingelheim from “Pilot to world-wide implementation and routine”. My intention to go the LogiPharma event is to meet people with similar challenges in serialization & aggregation and to up-date my supply chain management knowledge.

Key Supply Chain projects you are currently working on?
World-wide Implementation of Serialization, Track & Trace at Boehringer Ingelheim

What is your major investment area within the Supply Chain?
Investment into IT-solutions and to equip the packaging lines with the necessary serialization tools

What you foresee being your Supply Chain’s key challenge for the next 12 months, and how are you planning to overcome this?
To roll-out the necessary solutions to our internal and partially our external network.

What benefits do you plan to take home from LogiPharma?
As I am coming from the supply chain area, I am very much interested in new trends in SCM and of course to learn from the other participants of the pre-conference workshop on Tuesday

Frank Binder is Senior Director, International Logistics and Supply Chain, at Celgene, based in Switzerland. Currently his main task is growing and managing Celgene’s international pharmaceutical Supply Chain, optimizing the European distribution network while expanding the distribution network across Asia. He is guided by his team’s mission statement “Products to the Patients – Every Time, On Time – Compliant & Cost-effective”

Prior to this, Frank has worked in various Supply Chain roles at Hoffmann-La Roche, Novartis and at management consultancy Accenture. Thereby he’s gained a broad and deep Supply Chain Management expertise in the Pharmaceutical Industry, ranging from chemical production, biopharmaceutical manufacturing capacity planning, to logistics at a galenical manufacturing site, and finally to international logistics and distribution.

Key supply chain project you are currently working on:
Making our Supply Chain more secure against counterfeit and diversion

What is your major investment area within the supply chain?
Building a comprehensive Track&Trace system to handle world wide emerging requirements, eg California ePedigree, EU Falsified Medicines guideline, as well as other countries regulations, like Korea and Turkey

What you foresee being your supply chain’s key challenge for the next 12 months, and how are you planning to overcome this?
Optimizing and tightly monitoring our logistics processes to cope with a significant increase of volume mid term.

What benefits do you plan to take home from LogiPharma?
Meet fellow colleagues to understand if they are facing the same challenges, and share learnings with those that do

Prashant Yadav is a Senior Research Fellow and Director of the Health Care Research Initiative at the William Davidson Institute (WDI) at the University of Michigan. He also is on the faculty at the Ross School of Business and the School of Public Health at the University of Michigan. A leading expert on pharmaceutical and healthcare supply chains in developing countries, Dr. Yadav research explores the functioning of healthcare supply chains using a combination of empirical, analytical and qualitative approaches. He is the author of many scientific publications and his work on healthcare supply chains has been featured in prominent print and broadcast media. He also serves on the boards and advisory committees of multiple global health organizations. Prior to coming to the William Davidson Institute at the University of Michigan, Dr. Yadav was a Professor of Supply Chain Management at the MIT-Zaragoza International Logistics Program and a Research Affiliate at the MIT Center for Transportation and Logistics where he led the creation of a high impact research initiative focused on pharmaceutical supply chains in developing countries. From 2008-2010 he was also a visiting scholar at the INSEAD Social Innovation Center.

Key supply chain project you are currently working on:
Improving the supply chain for vaccines and medicines for infectious diseases in remote regions of less developed countries

What is your major investment area within the supply chain?
Investments in creating better supply chain information flow networks and creating better incentives for different stakeholders across the supply chain.

What you foresee being your supply chain’s key challenge for the next 12 months, and how are you planning to overcome this?
Stock outs of medicines, and lack of cold chain for vaccines are the major challenges being faced. Integrated supply chain structures and stronger incentives to invest in in-country supply chains will help us overcome these challenges.

What benefits do plan to take home from LogiPharma?
Perspectives of multiple experts in this sector on the unique challenges we face in supply chains in emerging markets and ways others have addressed them.

Riekert Bruinink is working at the Dutch Healthcare Inspectorate and held various positions, including management positions. Now he is a GMP/GDP Senior Inspector and specialized in Good Distribution Practice. He is also Chairman of the PIC/S GDP Working Group and Member of the EMEA GDP Drafting Group . This group is responsible for making a proposal for a new EU GDP Guide and procedures for harmonizing GDP inspections in the European Union. From 1981 until 1987 he worked as pharmacist in several public pharmacies. In 1987 he joined the Drug Inspectorate and in 1995 the Health Care Inspectorate in the Netherlands. Riekert Bruinink was awarded a MSc degree and a Pharm D degree by the University of Utrecht, the Netherlands.

Kristian Sibilitz, MSc in Engineering, has since 2009 been responsible for Logistics at H. Lundbeck A/S, encompassing new product introduction in the supply chain, direct purchasing, contract manufacturing, artwork management, production planning, product costing, warehousing and distribution. Prior to this, Kristian worked with planning, before taking responsibility for Lundbeck’s supply chain strategy and the management processes in the supply chain in his role as personal assistant to the Executive Vice President for Supply Operations & Engineering. As Vice President of Global Supply Chain, Kristian works with his organisation to strive for supply chain excellence from orchestrating suppliers to direct distribution and is constantly searching for innovative solutions to develop his organisation, while increasing reliability and reducing cost.

Key supply chain projects you are currently working on:
Improved supply chain planning across sites, introduction of new distribution centre and implementation of Supplier Performance Management System.

What you foresee being your supply chain’s key challenge for the next 12 months, and how are you planning to overcome this?
Managing the transition between products going of patent and launching a number of new products worldwide, while continuously improving reliability and reducing costs.

What benefits do you plan to take home from LogiPharma?
Inspiration for my strategy road map through best practice sharing, and building a broader network across the industry.

Until end of 2008, Jim Barrington was the Corporate CIO of Novartis.

Jim joined Novartis in February 2002 as CIOO (Chief Information Operations Officer) of Novartis Pharma AG, and in 2003 also assumed the position of Corporate CTO (Chief Technology Officer). Following this he was appointed Pharma and Corporate CIO and was a member of the PEC and the GFC.

Prior to joining Novartis, Jim was Senior Vice President and Group CIO with ABB in Zurich, Switzerland. Before that, he spent five years in Italy as Vice President of IT with the Whirlpool Corporation with accountability for all IT in Europe, Middle East and Africa, Asia Pacific, India and China. He also worked with Gillette for 10 years in the UK and Germany, and spent four years with Eli Lilly in Ireland.

Jim holds an MBA from Kingston University. He is married and has two sons and a daughter. Jim was born in Ireland and now lives in Basel, Switzerland with his wife. He enjoys outdoor activities and travelling.

Alessandro has a degree in Nuclear Engineering and one in Civil Engineering both held at Rome University, La Sapienza.

He is currently Senior Vice President, head of Supply Network Operations, in Merck Serono, a company belonging to the MerckGroup. He holds this position since August 2012.
In 2011, he has joined Merck Serono as VP, head of Global Supply Chain.

Previously, Alessandro has worked for more than 20 years in the FMGC’s industry heading different roles in production, engineering and supply chain in different countries (Italy, Spain, Belgiun and Switzerland).

In his early years, he has worked in the nuclear engineering research at ENEA (National Entity for Atomic Energy).

Alessandro is married with Catherine and he has one child, Nicolai. He leaves with his family in Geneva (Switzerland).

Key supply chain project you are currently working on:
Contract Manufacturing and Distribution in emerging markets What is your major investment area within the supply chain?

What you foresee being your supply chain’s key challenge for the next 12 months, and how are you planning to overcome this?
New EU GDP guidelines, emerging markets distribution capabilities, stricter quality requirements.

Piero Sciotto is Senior Director and Head of Product Supply at Daiichi Sankyo Europe GmbH in Munich/Germany, a pharmaceutical company.{br}He is in charge of topics like demand planning, supply & production planning, the S&OP process, pan European inventory levels, the management of contract manufacturers, procurement of direct material, the 3rd party distribution network, and supply chain performance monitoring. In the past he headed the departments “Application & Process Services Supply Chain Operations” and “Center of Competence SAP”, where he was responsible for strategic IT topics and acted as the project manager of Daiichi Sankyo’s European SAP Logistics rollout. Before taking up his recent positions at Daiichi Sankyo he worked for a leading automotive supplier in the role of a project manager. He graduated in industrial engineering at the Munich University of Applied Sciences, gained a PhD from the Otto Suhr Institute for Political Sciences at the Free University of Berlin, and is about to receive his MBA of the University of Wales.

Key supply chain project you are currently working on:
Introduction of an European executive S&OP, change of 3rd party logistics providers, reduction of costs of supply chain, streamlining of processes, improving performance management

What you foresee being your supply chain’s key challenge for the next 12 months, and how are you planning to overcome this?
Operating a streamlined and effective supply chain at low costs facing challenges like e.g. stronger regulations in the areas of supply chain security (GDP, the importation of active pharmaceutical ingredients + in the future: serialization)

What benefits do you plan to take home from LogiPharma?
Gaining interesting insights on what other companies are doing, which challenges they are facing and how they handle them. Furthermore of course having fruitful discussions with colleagues from other pharmaceutical companies.

Yoram has an MBA in Economics and Business Administration.

He has vast experience in global transportation systems and processes including all modes of transportation, Forwarding, Customs compliance programs, GDP and temperature management, Security, Safety and Environment implications.

Yoram has specialized in the Pharma and API industries including clinical trials, medical devices and bio pharmaceuticals.

Aviad has been with Teva since 2002. He held various positions as Commercial Operations Director in EU and Israel. Within these roles, he designed and implemented transformation of end-to-end supply chains as well as managing the on-going operation. He is focused on achieving quick results whilst building infrastructure of processes, systems and resources, in order to create value and identify potential synergies in the various supply streams.

In his current position, Aviad is Managing Director of S.L.E (a Teva IL subsidiary) – a leading pharmaceutical logistics & distribution company, providing wide range of supply chain solutions in Israel to global Pharma companies, with emphasis on excellence in quality and service.

Key supply chain project you are currently working on:
Putting into operation a national automated logistics center and transportation network which services a significant amount of Teva's production capacity into global markets, and global Pharma companies operating in Israel.

What is your major investment area within the supply chain?
The establishment of new state of the art, automated logistics center with advanced WMS technologies, interfaced with multiple ERP systems.

What you foresee being your supply chain’s key challenge for the next 12 months, and how are you planning to overcome this?
Deriving synergies in a central link of the chain where different streams of the Global Supply Chain interact - through more centralization and standardization..

What benefits do you plan to take home from LogiPharma?
Understand how other companies are addressing customers' and patient's current and future needs, and how they leverage logistics platform to provide better commercial benefits.

15 years in Baxter Healthcare Supply Chain. Started in various roles in Supply Chain Planning & S&OP management at EMEA level.

Since 2008, leading the customer operations in France & Benelux, in charge of Customer Service, Inventory & Demand management, Transport, W&D.

Member of the Senior Management Team of France-Benelux commercial organization as well as EMEA Supply Chain organization

Key supply chain project you are currently working on:
Segment & valorize customer front-end supply chain activities & services for full integration into commercial value proposition.

What is your major investment area within the supply chain?
Develop/hire talented and skilled people in the customer front end area (customer service specialist, customer project leader).

What you foresee being your supply chain’s key challenge for the next 12 months, and how are you planning to overcome this?
Flat sales, growing supply chain expenses – Drive cost saving / process efficiency initiatives (in W&D, distribution freight).

What benefits do you plan to take home from LogiPharma?
Networking, best practice sharing.

Peter Smith is Supply Chain Director for Baxter Healthcare EMEA, responsible for demand forecasting, manufacturing capacity planning and inventory management. Peter has had numerous roles in supply chain planning during his 18 year period with Baxter, with the last 4 being located out of the EMEA headquarters in Zurich. Peter has a Master’s degree in Supply Chain Management from Cranfield University in the UK.

Key supply chain project you are currently working on:
Optimisation of raw material inventories through the re-engineering of the MRP process.

What is your major investment area within the supply chain?
SC network design simulation. How to improve landed cost by moving from optimisation of the function, to optimisation of the value stream.

What you foresee being your supply chain’s key challenge for the next 12 months, and how are you planning to overcome this?
Managing the balance between aggressive top line sales expectations vs market reality. Development of the demand planning function (people/process/tools) is critical in managing this balance.

What benefits do you plan to take home from LogiPharma?
Networking.

For the best part of 17 years Val Petursson spent his time within a Global Supply Chain function, the last 7 within the Medical and Pharmaceutical sector.

Since Jan 2012, Val´s role has been to transform Actavis logistics into a state of art function, which is an exciting 3 year journey. In Nov 2012 – with the merger of Watson and Actavis – Val became responsible for International Logistics for the around 900 Supply Chains of the combined company.

Key supply chain project you are currently working on:
Implementation of all Actavis and Watson sites in to a single Control Tower. This is the first vital step towards our futurestate with full E2E visibility and maximum consolidation options for all transport from own sites and subcontractors.

What is your major investment area within the supply chain?
SAP – Infor from IT perspective. New consolidation hub in Romania for eastbound shipments. Project wise it’s the implementation of the Control Tower.

What you foresee being your supply chain’s key challenge for the next 12 months, and how are you planning to overcome this?
The merger will cause us challenges in all sectors of the SC, until we have both companies fully integrated in one single ERP system we are dealing with this task too manually. Once SAP implementation is complete we will get this in full control.

What benefits do you plan to take home from LogiPharma?
Understand how other companies are addressing the same kind of challenges within the Pharma Industry and pick up on new trends.

Egbert has joined Bayer in 2001 when he took over responsibility for production planning and logistics at a fully automated production site. Beginning 2005 within the Acquisition of Roche Consumer Health he moved to Basel and held several positions. During the last Years he was responsible for Global Supply Chain development of Consumer Care which includes global master data strategy and operations, global supply chain performance analysis and measurement and global sales & operations management.

Key supply chain project:
Supply chain master plan to improve flexibility, efficiency and standardization. Reduction of inventory without violation of service level.

What is your major investment area:
Harmonized tools and processes globally and knowledge improvement.

What you foresee being your supply chain challenge for the next 12 months:
Master data quality improvement for global supply chain reporting with a newly designed reporting platform.

What benefits do you plan to take home from LogiPharma?
Creative discussion and information exchange with few industry colleagues.

Dr Ulf Neuhaus was entering the Bayer AG in 2006 as an internal consultant for supply chain management. He was involved inseveral projects, which had the scope to develop and implement the supply chain processes standards in the Bayer HealtCare AG. After four years he changed to the department of Global Supply Chain Management, where he is now responsible for the further enhancement of supply chain processes with the focus on production and procurement planning.

Before that time, Ulf Neuhaus was working at the Technical University of Berlin in the department of Production Management as a research assistant. His focus area was on the development of quantitative methods to support the reactive planning of production processes in the chemical industry.

Key supply chain project:
Integration of external partners into our supply chain.

What is your major investment area:
Global process standardization and governance.

What you foresee being your supply chain challenge for the next 12 months:
Ensure sustainable process implementation into the organization by the reduction of process complexity.

What benefits do you plan to take home from LogiPharma?
Get insights in current trends and developments, Exchange of experiences with colleagues of the pharmaceutical industry.

Markus Ernst has been with Boerhinger Ingelheim since 1995 in his current postion, he is Head of IS Business Partnering Enabling Functions GBS based in Germany and he currently leads the SAP ERP Boehringer deplyoments worldwide from the IS perspective.

He has over 15 years experience in the areas of supply chain, financial and controlling processes within SAP ERP implementation projects in the pharmaceutical industry.

Markus is looking forward to share concepts, experience and ideas of global ERP SAP deployments especially in the supply chain area. Building relationships and set up networks.

Eric Leiglon is in charge, since 2008, of Ferring’s Demand & Supply Operations organization with global responsibility for Demand Management, Supply Planning and Customer Services activities. He is running the Sales & Operations Planning for the group and related sub processes (e.g. MPS at production site level). He is also the Global Process Owner for the Supply Chain Planning Suite. Before joining Ferring, Eric held managerial positions of increasing responsibility at Novartis (Supply Chain, Procurement and Logistics), in the luxury industry (Production, equipment engineering).

Eric holds a PhD in Technical Science from the Swiss Institute of Technology and a MBA (specialization in Supply Chain & Purchasing) from HEC Geneva

Key supply chain projects you are currently working on: 
Regional Packaging and Distribution
Distribution footprint optimization (including cost, service) in Europe
One set of data: system integration
Serialization

What is your major investment area within the supply chain?
One Supply Plan: end-to-end supply chain planning, including Sales & Marketing entities and Third Party Manufacturers
Constraint Planning
Supply Chain knowledge

What you foresee being your supply chain’s key challenge for the next 12 months, and how are you planning to overcome this?
Market uncertainties --> agility
Business opportunities vs inventory optimization --> responsiveness, lead time optimization

What benefits do you plan to take home from LogiPharma?
Exchange with peers, networking, collect new ideas to challenge own way of working.

Julian Amey joined ICI in 1978 as a control engineer. He had roles in engineering, production management, and production planning (on secondment in the US). From 1991 he had responsibilities for aseptic manufacture and new product introduction.

In 1994 Julian coordinated supply chain re-engineering in Zeneca Pharmaceuticals until in 1998 he headed up Zeneca’s Supply Chain Group. At the merger with Astra in 1999 Julian was appointed Vice-President of Supply Chains & Logistics and led work from 2002-2004 to implement lean approaches in AstraZeneca’s supply chain.

In 2005 Julian was seconded to Global R&D to lead and support change activities, before returning to Operations to lead the Transformation & Strategy Group. From 2008 he resumed leadership of the Global Supply Chain. He retired from AstraZeneca at the end of 2009 and joined Warwick University in 2010 as a Principal Fellow with advisory responsibilities for supply chain and operations management.

Monika Derecque-Pois is the Director General of the European Association of Pharmaceutical Full-line Wholesalers (known by its French acronym, GIRP). GIRP is headquartered in Brussels and brings together over 750 pharmaceutical full-line wholesaling companies and their national associations from 31 countries. Monika was appointed to her current position in 2001, having previously served as European affairs consultant for GIRP. In her role she represents the interests of pharmaceutical full-line wholesalers in Europe towards supply chain partners and decision makers at national, European and international level. Ms. Derecque-Pois has over 15 years of experience in European public affairs. Prior to her engagement with GIRP, she served as a director in a European affairs consultancy company. She also held a six-year post as a Marketing and Client Support Manager at IMS Health Austria, a multinational company specialised in information services for the healthcare industry.

Key supply chain project you are currently working on:
The European Medicines Verification System (EMVO)

What is your major investment area within the supply chain?
Since GIRP is an association representing full-line wholesalers, it is not part of the supply chain itself. However, one of the anticipated major investments for the pharmaceutical supply chain members will be the bar code scanners for reading the 2D Data Matrix codes, the changes of IT systems to accommodate risk based medicines verification on behalf of wholesalers and subsequently eventual changes in the layout of the warehouses. Finally the adjustments to comply with the new GDP guidelines which should be published within the next weeks will also require substantial investments.

What benefits do you plan to take home from LogiPharma?
LogiPharma provides us with excellent networking opportunities and the possibility to exchange views and experiences with colleagues from the pharmaceutical industry on supply chain issues and logistics.

Danny Hendrikse is a member of the Global Logistics & Supply Leadership Team and is responsible for the EMEA Logistics and Supply Operations, which includes Supply Chain, In Market Distribution and the European Logistics Center (ELC). He joined the Company in 1990 and held a number of positions in Logistics, supporting the Pharmaceutical, Consumer Healthcare, Confectionery and Shaving Products businesses in Belgium. After co-leading the Belgium Integration Team in 2000, Danny was appointed Director of Logistics at the ELC. In 2002, he was named Director/Team Leader of Logistics Operations. In 2006, he was named Site Leader, ELC. Danny has more than 20 years of operational and leadership experience in manufacturing and logistics.

He holds a degree in Distribution from the Antwerp Harbor Institute and a certification from APICS, the Association for Operations Management.

Danny enjoys family outings at great restaurants and city trips. He likes fitness, biking and Nordic walking.

Key supply chain project you are currently working on:
Segmentation of the Supply Chain

What is your major investment area within the supply chain?
SAP APO Deployment

What you foresee being your supply chain’s key challenge for the next 12 months, and how are you planning to overcome this?
Inventory reduction while maintaining performance, implementing the segmentation and implementation of SAP at the European Logistics Center (LEC is involved in more then 50% of Pfizer’s delivery chain). We will overcome those with very well thought through project structure and methodology.

What benefits do you plan to take home from LogiPharma?
Networking, understand new trends in Supply Chain.

Manel Luis is the Director Business Solutions for EMEA at Global Logistics and Supply Division at Pfizer’s subsidiary in Brussels. He has been with the company for the last eight years working in different locations (Spain, Italy & Belgium), after spending two years as a consultant at A.T.Kearney. During his career Manel has taken both Operations roles (managing the SC function in a Region including Italy, Greece, Turkey, Israel, Middle East and parts of Africa) as well as Strategy functions for the GL&S organization in his current role. At this moment Manel Luis leads the Strategic aspects of M&A and Buisness Development for the GL&S organization, Distribution Models, Channel Strategies, Network Optimization, LSP selection and contracting Knowledge base and in general interaction with senior Commercial roles and related projects between the Business Units and GL&S EMEA on a regional level.

He obtained his degree in Industrial Engineering from the Jaume I University (Castellon) and his MBA from ESADE Business School (Barcelona). Manel speaks English, Italian, Spanish, Catalan and some French. He is married, and has two children. In his free time he plays the piano and cooks for his friends and family.

Key supply chain project you are currently working on: 
Channel Strategies. Distribution models in Emerging markets. Segmentation of the Supply Chain and what this means for in-market Logistics.

What you foresee being your supply chain’s key challenge for the next 12 months, and how are you planning to overcome this?
Servicing segments of the product portfolio/divisions with different set ups but still leveraging the synergies and scale of the company.

What benefits do you plan to take home from LogiPharma?
Latest trends, networking, opportunity to share/validate strategies and good contacts with potential future partners.

Iain Richardson is currently Senior Director Global Supply Chain and Logistics for Eli Lilly and Company, responsible for global demand management, supply chain planning, risk management programmes and logistics. He is also responsible for Lilly’s Legacy Product portfolio, and Transfer of Technology as part of Lilly’s philanthropic MDR-TB programme. Iain has been involved in the MDR-TB programme since its beginning in 2003.

Born in Scotland, Iain has a Bachelor’s degree in Chemical Engineering from the University of Edinburgh and a Masters in Biochemical Engineering from University College London.

Iain has been with Lilly for 26 years since joining at the company’s Liverpool facility in England as a Technical Services Associate. Prior to his current role, he was Director Contract Manufacturing for Lilly’s external manufacturing operations in Europe, Asia and North America.

Dirk Schrader is Head of Industrial Operations and Member of the Executive Committee for Vifor Pharma, based in St. Gallen and Zuerich/Switzerland.
Vifor Pharma is a world leader in the discovery, development, manufacturing and marketing of pharmaceutical products for the treatment of iron deficiency. The company also offers a diversified portfolio of prescription medicines as well as over-the-counter (OTC) products. Vifor Pharma, headquartered in Zurich, Switzerland, has an increasingly global presence and a broad network of affiliates and partners around the world.
Before joining Vifor Pharma, Dirk worked for AstraZeneca for 5 years first as VP Supply Asia Pacific/Japan in Singapore and then as VP Lean Global Operations based in the UK. Before that he held the role of VP Operations & Supply Asia Pacific/Japan for Bristol-Myers Squibb in Singapore and prior to then held a number of technical and commercial roles at Bayer including Head Technical Operations in China and SVP/International Technical Operations and General Manager/Commercial Head of the HealthCare Business in Taiwan. Dirk earned a PhD in Pharmaceutical Technology from WWU Muenster, Germany.

Helena Buckley is the Global Talent Director for Johnson & Johnson Supply Chain supporting the Janssen Supply Chain and Customer Logistics Services Organisations. Helena has over twenty years experience in Human Resources across a range of industries in Medical Devices, Pharmaceuticals, Commercial and the service Industry. Helena’s experience to date has focused on culture change, leadership, strategy execution and organisational effectiveness. In her current role Helena is focused on developing strategies and implementation plans in Supply Chain focused on workforce planning, career management, talent acquisitions for critical positions and accelerated leadership development processes for identified talent pools. Helena holds a Bachelor of Business Studies Degree and is a member of the Chartered Institute of Personnel and Development.

• A technology leader with extensive project management, general management and IT project leadership expertise.
• 20+ years experience delivering technology projects within pharmaceutical, chemical, oil and gas and FMCG across large and multinational organisations.
• Investigated, developed and deployed operations data strategy to create a step change in business performance across Operations Supply Chain.
• Delivered the mass migration of data from 24 legacy systems into a unified European SAP platform
• Created a cross functional team to lead and manage the business processes, teams and technologies delivering the right information at the right time to ensure the business realises strategic ambitions.
• Built cross system, business wide global data governance process to ensure critical business data to drive supply chain is maintained and improved.
• Delivered Operations-wide implementation of Information Management Technology to consistent standards and processes.
  
  

SVP of the Corporate Division Quality & Environm. Health and Safety

He studied pharmacy at the Johann Wolfgang Goethe University in Frankfurt/Main and made his PhD in Pharmaceutical Technology.

Since 1981 Thomas Zimmer is with Boehringer Ingelheim where he had several positions in the Pharmaceutical Development and Pharmaceutical Manufacture and in the Area Management Operations (Americas, Europe). He was also Head of the Project Production Alliance Europe (PAE ) and later Head of Pharma Operations at Boehringer Ingelheim France. Since 07/2000 Thomas Zimmer is Senior Vice President of the Corporate Division Safety, Quality & Environmental Protection.

Virginia Herold is the executive officer of the California State Board of Pharmacy, a position she has held since July 2006. Prior to this appointment, Ms. Herold served as assistant executive officer of the Board for 16 years.

A graduate of the University of California, Ms. Herold holds Bachelor of Science and Master of Science degrees. Her education involved a blend of consumer protection, economics and textile chemistry. She has focused her career on consumer protection. Before coming to the Board, she served as publications editor for the Department of Consumer Affairs and manager of the Department of Consumer Affairs Legislation Office.

As executive officer, Ms. Herold works closely with and advises the 13 Board of Pharmacy members in the development of policy and in the administration of the board’s enforcement, licensing and regulatory programs to further the board’s consumer protection mandate. The Board regulates over 130,000 licensees in 25 separate regulatory programs including pharmacists, pharmacies and drug wholesalers.

Chetan’s experience in Supply Chain management spreads out through different industries both in Indian and International Markets. In his present role he is working as the Director of Supply Chain for Baxter India where his team is responsible for end to end Supply Chain Management for the organization including providing support in the areas Purchasing & Supplier Management for all raw materials/packing materials and non production purchases, logistics operations including warehousing, transportation, import/exports, SC Planning & inventory management and Technical services support.
Chetan moved into Baxter India from Schneider Electric Asia Pacific Ltd, Hong Kong, where he worked on various Global Supply Chain & Logistics Projects as a part of the Asia-Pacific Supply Chain team, prior to joining Schneider Electric he has also worked with BAX Global India Ltd’s Logistics arm and had started his career in manufacturing plant operations in automotive industry. He has over 12 years of experience in the field of Supply Chain and Logistics.

Key supply chain project you are currently working on:
Network optimization to reach to tier 2 and tier 3 cities across India for a wider reach of supply chain network.

What is your major investment area within the supply chain?
Investments in creating better supply chain networks and stock points with enhanced informatics to help enhance deliveries to patients/hospitals.

What you foresee being your supply chain’s key challenge for the next 12 months, and how are you planning to overcome this?
Key SC challenge in emerging markets would be reach to market and we would need to have a phased approach to overcome this challenge.

What benefits do plan to take home from LogiPharma?
Learning from experts with vast knowledge from the industry that would enhance SC operations of the organization.

Thomas Ebel is a Partner in McKinsey's global Pharmaceutical Operations practice and the European Supply chain practice, located in the Düsseldorf office. He supports companies in Pharmaceuticals and Consumer goods in transforming their end-to-end supply chains, optimizing service, working capital, and total cost of supply, as well as building the right capabilities to support growth and profitability. His projects include Supply chain strategy, the integration of suppliers, supply chain planning and S&OP, inventory management, sales forecasting, and distribution. He leads the global POBOS Supply chain benchmarking service line to drive comparable performance benchmarking in the pharma industry.

Thomas holds a degree in business administration from the University of Bamberg. He joined McKinsey in 2005, after holding different positions in Supply chain, Commercial, and IT/ERP-management in retail for 10 years.

Dr. Oliver Scheel has been with A.T. Kearney since 2000. With 18 years of combined consulting and industry experience, he is a leader in A.T. Kearney’s Health Practice in D/A/CH. He is also responsible for End-to-End Complexity Management team across industries as part of the EMEA Operations Practice. He has multi-year experience in strategic operations consulting with a focus on designing integrated end-to-end supply chain and distribution networks in global Pharma and Consumer Goods companies.

After a master and PhD in biochemistry he started his career at Beiersdorf in R&D with Nivea products. Then he moved to L’Oréal where he worked as a Sales Manager and later in Marketing as Group Product Manager for Garnier as a brand, specializing later in career in supply chain and operations.

Key supply chain project you are currently working on:
End-to-end complexity optimization of a product and customer portfolio for a global Pharma & Consumer company to drive a lean and agile supply chain and distribution network

What is your major investment area within the supply chain?
Developing new breakthrough concepts for future supply chain and distribution networks in pharmaceuticals which are lean and agile, delivering the optimal end-to-end performance for the whole enterprise and customer ecosystem

What you foresee being your supply chain’s key challenge for the next 12 months, and how are you planning to overcome this?
Establishing and / or keeping top service level and quality performance at reduced costs in a more and more complex global environment with a myriad of different and ever changing regulatory, market access and trade/ customs restrictions

What benefits do you plan to take home from LogiPharma?
Discuss and challenge current situation of Pharma companies regarding the operations of their supply chain and distribution networks and broaden own international expert network

Pablo Moliner has been with A.T. Kearney since 2001. Over the last ten years, he has supported multinational pharmacos in the design and implementation of alternative distribution models and point-of-sale commercial strategies across Europe, North and South America and Asia. In parallel, he has designed new services strategies and market access strategies.

Key supply chain project you are currently working on:
Design and implementation of alternative distribution models, direct-to-pharmacy and seduced wholesalers models in Eastern and Southern Europe. Design of commercial trade channel strategies across Europe and Asia

What is your major investment area within the supply chain?
Increasing Supply Chain integrity and maximizing trade channel commercial upside across company portfolios

What you foresee being your supply chain’s key challenge for the next 12 months, and how are you planning to overcome this?
Maximizing the commercial upside of the trade channel as pharmaceutical companies re-discover the importance of pharmacies in driving demand for their products

What benefits do you plan to take home from LogiPharma?
Sharing best practices and real life experiences with a broad range of industry experts

Doctor in Pharmacy plus business school, Jean-François has spent 10 years in a pharmaceutical company as Supply Chain Manager and Deputy Pharmacist. After 4 years in merchant banking as responsible for a portfolio of subsidiaries and participations, he started a career in the Healthcare LSP with different positions : Operations Director, Project Director, and since 2008 Europe Pharmaceutical General Manager covering the functions of QP for France and Switzerland and assuring the healthcare compliance at corporate level.

As a responsive leader he developed operative and innovative solutions with a view to participating efficiently to market needs and evolutions.Participating to the profession development and representation he’s the President of the French depositaries organization LOGSanté. In 2010 he collaborated to the creation and was elected Chairman of EALTH the European Association for Logistics and Transport in Healthcare which represents the logistics and dedicated transport service providers to the European Institutions and Organizations.

Mohammed Esa is Agility’s Chief Executive Officer for Dubai and Senior Vice President for the United Arab Emirates, Oman and Bahrain. Mr. Esa has been with the Agility for eight years and is responsible for providing leadership and growing Agility’s business in Dubai.

With over 15 years of experience in the transportation industry in the Middle East, Mr. Esa works closely with the CEOs of Abu Dhabi, Oman and Bahrain in order to provide them with strategic direction. He also oversees the achievement of Agility’s objectives in these markets.

Mr. Esa previously spent two years as Agility’s Senior Vice President, Middle East and Africa, where he was responsible for the group’s sales and marketing initiatives in the region covering 15 countries. During this period he was integral in shaping the sales and marketing strategy and developing partnerships with key customers.

Prior to this, Mr. Esa was based at Agility’s Hong Kong headquarters, where he played a key role in setting up a regional sales team and managed several strategic customer relationships.

Mr. Esa holds an MBA from the University of Bradford in the U.K. He is married with three children and enjoys playing tennis, golf and spending time with his family.

Leif Kronkvist is Agility’s Senior Vice President of Business Development for GIL Europe. Mr. Kronkvist has been with Agility for 5 years and is responsible for business development and customer relationship management in Europe covering all modes of transportation with a special focus on Life Science.

With over 20 years of experience in the transportation industry in Europe, Mr. Kronkvist has extensive knowledge in Strategic Sales Management, Supply Chain Management, Project Management, Contract negotiation, and Pharmaceutical GDP.

Mr. Kronkvist brings comprehensive expertise in the development and implementation of customer interface processes such as Tender and Solution Design. He leads a team of Country Sales Managers, Regional Key Account Managers, as well as the Tender and Solution Teams for Europe. He is in charge of shaping the Sales & Marketing Strategy for the region, growing the partnership with key customers and developing Agility’s Life Science Sector.

Mr. Kronkvist worked in Sweden and Germany. He is now based in Basel, Switzerland.

Tim Gittins is the IT Director for Alloga Europe and is responsible for the development and delivery of the groups IT Strategy and has worked in the area of Pharmaceutical Pre Wholesale for nearly ten years. Mr Gittins held the position of IT Director at UniDrug Distribution group before moving to Alloga to head up their European IT. Tim holds a Honours Degree in Computing Science from Nottingham Trent University and has worked in IT for over 25 years.

Julia Smirnova was born in Riga (Latvia) in July 7, 1971.
She has graduated from the Latvian State University, the Faculty of Philology and Foreign Languages in 1993. She obtained Master of Business Administration degree in 2003. Since 1991 till 2000 she was gradually passing her milestones in transit business of chemicals and petrochemicals polishing her professional skills in daily business communication with BP, Cargill, Glencore, Mitsui, Norsk Hydro managers. In 2001 she was invited to join the team of one of the biggest Latvian distributors of FMCG as the Marketing Director also responsible for the business development. During her working experience she used to attend various training courses including “Stress Management Courses”, “Time Planning Courses”, “Negotiation skills. Business communication Courses”, ”Brand Management courses”, ”Team Building and Successful Communication Trainings”, “Professional Management Trainings”, ”Operational Marketing” and others.
Since 2010 and till present moment she is the Senior Business Development Manager and active member of the pharmaceuticals logistics provider Astra Logistic Ltd..

Michael Jarosch joined Camelot Management Consultants in 2008 leading the Pharma and Medical Devices industry line of business and is a member of the management team at Camelot. Prior to Camelot he had positions as Vice President for Ernst & Young/Cap Gemini and as a Partner at Unisys.

Michael is a top management consultant with more than 20 years of extensive experience in strategy and operating model design, post-merger integration, operations/supply chain management, marketing & sales, Customer Relationship Management and OPEX/Lean. He led numerous international projects with top and medium sized Pharma/Life Sciences clients as well as in the consumer products industry.

Michael is an expert for Organization design, business transformation and organizational change management. He delivered significant organization, process and system implementations especially in the Pharma/Life Sciences industry with a special focus on supply chain management innovation and transformation.

Andreas is founder and managing director of CNT Management Consulting, a global management consultancy focusing on ERP strategies and solutions for the pharmaceutical and engineering industry. The company is specialized on driving business value through system consolidation programs, optimizing and transforming of supply chain processes and enabling global IT-solutions.

The career has been focused on international projects over 22 years, encompassing pharmaceutical, retail and engineering industry. He was leading complex ERP implementations as project manager in more than 10 different countries worldwide and gained experience as expert in the area of supply chain processes and production controlling. He holds a master degree in computer science and a master degree in business administration.

Andreas is looking forward to share concepts, experience and ideas with a clear vision enabling operating models which work pragmatically and efficiently in today’s complex, global business environment of pharmaceutical supply chains.

As Austrian citizen Andreas loves skiing, mountain biking and kite surfing.

Key supply chain project you are currently working on:
Global process standardization and harmonization supported by enterprise resource planning programs, driving end-to-end integration of supply chains

What is your major investment area within the supply chain?
Supply chain process management, process standardization/harmonization, enterprise resource planning, advanced planning solutions

What you foresee being your supply chain’s key challenge for the next 12 months, and how are you planning to overcome this?
Serialization, mobile and on demand solutions enabling to plan, track, trace material flows from our suppliers’ suppliers to our customers’ customers.

What benefits do you plan to take home from LogiPharma?
Insight what the pharma industry is doing and getting feedback on what we do, new contacts, networking

Kerry Pickstone is a Managing Consultant with the UK's leading end to end supply chain consultancy, Crimson & Co. Previously she worked with Australia’s largest retailer Coles Myer in a number of roles, developing network capacity, driving operational improvement, and later managing the Sales and Operations Planning process for the non-food division.

A specialist in leading change across the supply chain Kerry’s more recent experience has been in business integration, implementing above market planning and driving operational excellence in global businesses. Sector experience includes consumer goods, retailing and pharmaceuticals. As well as Australia, Kerry has worked across Europe, South America, Africa and the Middle East

Paolo Rosanna was appointed VP, Head of Business Development in January 2012 to lead the Business Development agenda for the Life Sciences & Healthcare Sector in EMEA.

Following his degree in Business Administration with a major in Marketing at the Università Commerciale Luigi Bocconi of Milan, Paolo started his career in international Freight Forwarding in the UK, USA and Italy with MSAS Cargo International. Paolo developed his expertise across operations and business development, focusing on Life Sciences & Healthcare, staying with the company as it was acquired by Exel in 2003 and then by Deutsche Post DHL in 2006.

In 2007 Paolo moved from DHL’s Global Forwarding division to its Supply Chain division, as Business Development Director for Italy and then into the roles of Head of Life Sciences & Healthcare Development Mainland Europe and Vice President Business Development Western Europe.

Paolo was born in Stresa, Italy, in 1965 and is married with two sons. In his spare time he is passionate about football.

Fabio Mioli is Director, Business Development Life Sciences and Healthcare (LSHC), DHL Supply Chain EMEA. He joined DHL in November 2010 from Wyeth Pharmaceutical, where he was responsible for Supply Chain and Commercial Operations, including sales forecasting, distribution and trade, mature product portfolio and hospital tender management.

Prior to that Fabio worked for the pan-European pharmaceutical wholesaler, Alliance-Boots / Alliance Healthcare, as Commercial Affairs Director for Italy, with responsibility for Industry Relationships, Generics (Almus) and Pre-Wholesaler (Alloga).

Fabio’s other roles have included Head of Procurement for Schering-Plough, Italy and Purchasing Manager for Procter and Gamble.

Fabio graduated in Mechanical Engineering.

Geert Robbrecht is Director of Business Development for the Life Sciences and Healthcare sector across Europe, Middle East and Africa (EMEA) for DHL Supply Chain. Geert has been in this role since March 2011 and his principle responsibilities include supporting healthcare companies to set up and optimize their supply chains in the EMEA region.

Geert has worked for DHL for over ten years, starting his career with the company as a Logistics Engineer in 2001. He has been part of the Life Sciences and Healthcare sector for six years, and before becoming Director Business Development, he was the Commercial Manager for Healthcare at DHL Supply Chain. In this role he had responsibility for commercial growth and development of Belgium for four years.

Geert holds a Masters in Applied Business Economics from Ghent University in Belgium alongside a Special Degree in Transport and Harbour Economics from the same institute. In addition Geert also holds a Masters in Logistics from the Karel de Grote School in Antwerp.

Outside of work Geert lives with his partner and two sons. Each year he helps to organize the two-day Crammerock pop and rock festival.

Tommy Weston is the director of the international division of Bech-Hansen & Studsgaard with branches in Copenhagen and Aarhus. He is also responsible for the development of the European partner network and the sales organization.

Apart from his position at BHS, he is also managing Director and boardmember of the co-owned company Nordic Chain AB and boardmember of the co-owned company Pharma Logistics Alliance Europe CVBA (PLAN Europe). PLAN Europe is the first asset based pharma logistics network, setting new standards for Pharma logistics all over Europe.

Tommy has over 27 years of experience from the international forwarding, transportation and logistics industry and worked in both corporate and privately owned companies.

Also on management and executive management level, he has over 20 years of experience within the same industry.

Andy is a Director at Infosys Lodestone in UK with 15 years of supply chain consulting experience in a range of industries but especially Life Sciences and CPG.
He started his career in industry working at ICI for 9 years in Sales & Marketing roles, moving to Supply Chain Planning and Operational Excellence before becoming a management consultant.

In consulting Andy has worked for PwC and IBM, before joining WCI, a specialist in Healthcare, Life Sciences and Operational Excellence, and in 2011 Infosys Lodestone. Specializing in supply chain, he has supported business transformation projects and programs, both multi-year global systems integration programs and operational excellence process improvement initiatives. A focus in recent years has been the application of people centred collaborative processes and technologies, to enhance capability and decision making in supply chain.

Andy holds an MA Hons in Natural Sciences from Cambridge, and CPIM from APICS, and is trained in programme and change management and operational excellence methods.

As Vice President of Thought Leadership, Trevor serves as an expert source for Kinaxis customers, prospects, industry analysts and journalists. Known throughout the supply chain field, he has published many articles, presented at various industry events, and is the primary contributor to the Kinaxis 21st Century Supply Chain blog. Trevor helps Kinaxis seek new market opportunities within the company's distinctive competence and is instrumental in the company's competitive and market intelligence. He helps key customers achieve the operational control tower vision, guiding their priorities and architectures to realize the full potential of RapidResponse.

Having lived, worked, and studied in Canada, the United States, Europe and Africa, Trevor brings a global perspective to market needs and customer requirements. Prior to joining Kinaxis, Trevor worked for i2 Technologies where he held a number of sales & marketing roles and worked with global industry leaders such as Continental, Volkswagen, Nokia, and Thomson. Previous to i2, he worked for Coopers & Lybrand performing several studies in supply chain reengineering for companies such as Levi's, Burmah Oil, TNT Logistics, AGA Gas, and Schneider Electric, among others. Trevor has degrees in Chemical Engineering and Industrial Engineering.

Martin Eckert has been with Miebach Consulting for over 20 years and a long-standing experience both in Supply Chain Management and Material Handling Engineering, especially within the Pharmaceutical & FMCG industry. After various positions with Miebach Germany and Miebach Spain he was responsible for the development of the Miebach network in North and Latin America with today 8 offices stretching from Indianapolis to Buenos Aires.

Since 2000 Martin was Managing Director of Miebach USA where he consulted many blue chip companies like Eli Lilly, Amgen, Pfizer and Wal-Mart, Nestlé, Procter & Gamble, as well as Daimler Chrysler or Porsche in the automotive sector.

In 2012 Martin returned to his home country Germany and is now using his broad experience and knowhow in supply chain projects in Germany and Europe. His present position is Director at Miebach Consulting Germany.

Key supply chain project you are currently working on:
Global Supply Chain End-to-End Visibility Project with strong focus on Lean principles.

What you foresee being your supply chain’s key challenge for the next 12 months, and how are you planning to overcome this?
Tracking & Tracing as well as SC visibility are key factors for achieving supply chain excellence in the pharmaceutical industry. They must be realized in order to compete in a globally connected industry with uncountable national regulations.

What benefits do you plan to take home from LogiPharma?
Networking, exchanging fresh ideas, giving as well as receiving market insights.

Torben Vogt is a Life Science Industry Expert at NNIT, responsible for Business Development of Serialisation and Track & Trace.

He has 25 years of experience from the industry and has been working at management level in number of functions, spanning from Finance, Planning, Logistics, Supply Chain, Sales & Marketing to IT.

Prior to NNIT, he worked for 7 years at generic pharmaceutical leader Actavis, starting as Director for the global ERP programme and later appointed VP of IT with responsibility for Europe and Asia, working closely with the business management.

Ann Merchant is President of Schreiner MediPharm, a business unit of Schreiner Group based in Oberschleissheim near Munich in Germany. Schreiner MediPharm develops and produces innovative, multi-functional specialty labels with value-added benefits for the pharmaceutical industry. Ann is responsible for the sales organization, global strategy and further development of the business unit building on the worldwide network of sales representatives and local US production.

Prior to joining Schreiner MediPharm, Ann was VP International Supply Chain for Amgen Europe BV in The Netherlands. There she was responsible for Amgen Inc.´s sole international packaging and distribution facility as well as Operation´s primary point of contact for international expansion efforts in Middle East Africa, CEE and South America. She has over 20 years of pharmaceutical industry experience in the areas of financial planning, strategic decision support and global commercial supply strategy at both the corporate and affiliate level in the US and Europe.

Ann holds a BSc in Languages from Georgetown University in Washington D.C., and a Master in Business Administration from Henley Management College, UK.

Jolyon Austin leads Accenture’s Europe, Middle East and Africa Life Sciences Supply Chain Practice.

He works with clients to define and realise sustainable step changes in supply chain performance – partnering with them on the journey from definition of an operating strategy through to on-the-ground implementation and realisation of the business case.

Jolyon has extensive experience of supply chain strategy, supply chain planning and customer logistics strategy as well as design, implementation and operations improvement.

He has held roles in industry and consulting in the pharmaceutical, consumer goods and retail industry sectors. Prior to joining Accenture, he worked for Procter & Gamble Product Supply in manufacturing and supply chain roles.

Jolyon has an MSc in Physics from the University College of Wales, Aberystwyth and is a Chartered Fellow of the Institute of Logistics and Transport (UK).

Shabbir Dahod, President and CEO of TraceLink, has been a cutting-edge innovator focused on the intersection of technology, business and management to improve corporate performance for over 29 years. He led new collaboration and knowledge management initiatives at Microsoft before launching numerous startup companies including SupplyScape Corporation, the de-facto leader in software solutions to safeguard the pharmaceutical supply chain. For over a decade, Shabbir has been directly involved with the development of standards, creation of technologies and analysis of business operations related to pharmaceutical compliance in both global pharmaceutical traceability and global quality management.

Robert Ljoljo is director of Supply Chain Management for company LEK d.d., member of Sandoz group. He is responsible for supply chain of
Sandoz Slovenian manufacturing operations and for Commercial supply chain in several countries in South Eastern and Central Europe, for which distribution
is managed out of Slovenia. He is member of Sandoz Global Supply Chain team.

Robert holds Masters of science in management and information technology. He has 15 years of experince in Generics Pharmaceutical industry in different roles, mainly in area of manufacturing, quality management and supply chain.

Before he joined SC team in 2009, Robert was heading Sandoz Global competence center for Manufacturing Execution Systems, being responsible for rollout of IT solution worldwide in Sandoz network.

Key supply chain project you are currently working on:
Improve reliability capabilities of Supply Chain in the environment of increased complexity.

What is your major investment area within the supply chain?
Implementing Track & Trace system, to comply with emerging legislations.
Consolidate distribution facilities for Slovenia supply network.

What you foresee being your supply chain’s key challenge for the next 12 months, and how are you planning to overcome this?
Managing reliable supply chain operations within the network of manufacturing plants rather than individual sites.
For this we on boarded a journey with sets of projects and process changes.

What benefits do you plan to take home from LogiPharma?
Get latest leading edge thinking of pharma and generics industry and collect additional inputs for update of global SC strategy. Better understand our competitive advantage and key items to work on in future.

Diana Zmicerevska was born in Riga (Latvia) in March 10, 1976. She has graduated from the Latvian State University, the Faculty of Philology and Foreign Languages in 2000. Gained her BA Degree in Economics and Qualification of Economist in Business Activity Economics in 1997, Master of Science in Economics in 2000. At present Diana Zmicerevska is PhD candidate in Business Administration. Experience in other positions has afforded Diana the opportunity to become familiar with different aspects of business and gain experience in various fields. She had been teaching for almost 10 years in Information Systems Management Institute in Riga, Latvia, and held CEO position in consultative company from 2006 till 2011. She has experience working in the Parliament of Latvia and wide experience in market and business research due to working on different projects financed by the EU structural funds. During her working experience she used to attend various training courses and professional training programs. Since 2013 she is the Business Development Department Manager and active member of the pharmaceuticals logistics provider Astra Logistic Ltd.

Mr. DeJean, Vice President and veteran of Systech International for more than 25 years, is responsible for Systech’s Subject Matter Expertise Center, driven to support and educate customers and stakeholders on best practices for implementing a serialization program. As a member of the Executive Leadership Team, David brings a wealth of market knowledge, hands-on experience in serialization technology development and project execution. David’s key activities include staying abreast of international regulations, business and industry drivers, and supporting customers and stakeholders, defining high performance and cost efficient solutions that are integrated and expandable to meet future needs. David is a serialization subject matter expert previously holding various roles within Systech including, Engineering Management, Product Marketing, Professional Services and Sales Management.

Antioco Cerina is currently the Supply Chain Global Production Planning Process Stewardship Director for Bristol-Myers Squibb. He holds a bachelor degree in Mathematics and Information System and started his career in the Information System area where he acquired a solid experience in complex systems and processes implementation techniques. He has been working for the last 24 years in different countries in Europe and USA where he had various managerial positions in the Procurement and Supply Chain fields both in regional and global positions. He is an APICS certified Supply Chain Professional and holds a Green Belt certification. He has been using extensively business process improvement methodologies to shape supply chains and drive business value for the healthcare industry. He is looking forward to share and exchange experience and ideas during the Logipharma conferences on how to position the supply chain Process Excellence as a strategic asset within the pharma industry.

What you foresee being your supply chain’s key challenge for the next 12 months, and how are you planning to overcome this?
The overall Pharma Industry landscape and its associated business challenges is not very different from what we see happening in all other markets because of the overwhelming financial crisis affecting every industry sector since 2009. I would not define this new situation an exception thought, but much more the new normality of the business as some of the challenges, as the industry stricter regulation and market access, are certainly peculiar to the Healthcare business and do require a perpetual process change strategy and new ideas to adapt to the new reality. Process and operational excellence, and its associated cultural change to a more disciplined corporate mindset is, in my view, one of the good answers to respond to those changes on a perpetual basis.

Key supply chain project you are currently working on:
In 2013 my team and I will continue to continue to design and evolve new processes such as Supply Network Planning and Business Planning and to integrate them to our operational planning processes to create a competitive and benchmarking Supply Chain organization.

What is your major investment area within the supply chain?
Supply Network Planning and S&OP process design and tool configuration and implementation.

What benefits do you plan to take home from LogiPharma?
I come to Logipharma to meet peers and learn about experience from Supply Chain partners partners working with both healthcare and other industries . Exchange ideas and learn different perspectives on common problems is certainly the best way to benchmark our company with others. Least but not last, meet great people and have fun.

Elisabeth Kaszas has worked at Amgen Sales & Marketing, Operations, and Supply Chain Management for the past 17 years. She has experience with both the clinical and commercial supply chain functions of biopharmaceuticals. She recently led the implementation of North America supply chain, demand and supply planning and inventory management. She previously led the global design and implementation of advanced planning processes and systems for optimizing demand, production planning and inventory control, now used across all regional, site and corporate functions. Prior to joining Amgen, Elisabeth managed new product introductions to the European market at Baxter International Inc. and Pharmacia Biotech Inc. She holds an M.S. in Biotechnology from ENSAIA, as well as an MBA in International Management from ESSEC, France.

Martijn Lofvers is owner of Supply Chain Media and founder of the Dutch Supply Chain Magazine (in 2006) and the European quarterly magazine Supply Chain Movement (in 2011).

The mission of Supply Chain Media is to connect supply chain professionals worldwide and provide them with strategic knowledge to use in their daily practice. Supply Chain Media is one of the few international media companies specialized in supply chain management in Europe. Martijn Lofvers has excellent connections with European supply chain executives and with the academic world (MIT in Boston and IMD business school in Lausanne). Through this network Supply Chain Media establishes an actual exchange of supply chain experience and knowledge.

Martijn Lofvers and his team has developed several innovative content formats about supply chain management, such as:

• Subway Maps
• Mind Maps
• Self Assessments
• A Supply Chain Map of Europe
  
  Previously Lofvers has worked as publisher for Springer Science + Business Media (5 years) and Reed Elsevier (12 years). He holds a university degree in technical engineering and business science from the Eindhoven University of Technology with a specialization in Operations Research. He also published a war novel and a non-fiction book about the history of supply chain management, both in Dutch.
  
  

Marcus LeMaster is Business Development Director for Zuellig Pharma Specialty Solutions Group (SSG), a division of Zuellig Pharma, Asia’s leading pharmaceutical and healthcare distribution company.

Based in Singapore, Marcus is responsible for strategy, innovation, and solution development around regional logistics services for the pharmaceutical and healthcare industry. Marcus and his team work with Principals both in supporting their entry and growth into Asia, as well as streamlining their supply chain operations to achieve the desired cost efficiency and market responsiveness.

Marcus’ portfolio includes SSG’s state-of-the art Regional Hub in Singapore with large-scale GMP redressing and cold-chain capabilities, and ZiP CHECK, Zuellig Pharma’s own serialization and anti-counterfeit solution.

Marcus has over 20 years of professional experience in supply chain, logistics, transportation, and IT. Originally from the US, he has worked internationally for 17 years, with the past seven years spent in the Asia-Pacific region.

Johan Beukema is Partner for Healthcare Supply Chains at Buck Consultants International. As a Partner and co-owner of the company he is responsible for BCI’s activities in the pharma, biotech and medical devices industries. Johan holds a degree in Business Administration of the University of Groningen in The Netherlands, did part of his studies at the Business School of the University of Tampere, in Finland and has done multiple higher education programs in supply chain management and logistics during the last 15 years besides his professional career.

As part of BCI, Johan is an expert in supply chain network strategy, modeling and redesign. He also has a wide experience base in order to cash and customer service organization development as well as logistics outsourcing. Apart from the typical consultancy role he is involved in many complex implementation processes, where his role is much more involved in coaching, external support and/or taking real ownership of part of the implementation process.

Johan has worked with many leading pharmaceutical companies. Examples include Baxter, Celgene, Amgen, UCB, Eli Lilly, Takeda, Novo Nordisk, Abbott, and Ariad to name just a few. He publishes regularly about healthcare supply chain development and is a regular speaker at events.

Aleksandr (Alex) currently leads Novartis Region Europe Channel Management team, managing commercial relationships and developing new marketing and commercial model approaches in pharmacies, hospitals and wholesaler channels.

Prior to joining Novartis, Alex built up a broad base of commercial, marketing and sales experiences in the US and Europe across pharmaceutical, biotech and medical device industries. He holds an MBA from the Wharton School of the University of Pennsylvania, and a masters degree in engineering from the City University of New York

Michael Weidel has over 20 years of experience in software and manufacturing companies, where he has held various positions including product management, professional services, business consultancy, and sales. Today, he is account manager for the Infor supply chain management solutions, which include Sales & Operations Planning, Demand planning, manufacturing planning and scheduling, network design and supply chain execution solutions.

Richard Buxton has been with Infor for over 12 years and during this time has focussed on working with life science clients on implementing Infor’s Integrated Business Planning suite to assist in the unique challenges faced within this industry.

These projects range from Global to Pan European to Country specific projects and range from end to end IBP projects to Demand Planning centric projects to factory scheduling projects.

Notable Infor customers Richard has worked with include Actavis, Mundipharma and Smith & Nephew

Markus Bauss is Senior Sales & Project Manager of Schreiner MediPharm, a business unit of Schreiner Group based in Oberschleissheim near Munich in Germany. Schreiner MediPharm develops and produces innovative, multi-functional specialty labels with value-added benefits for the pharmaceutical industry. Markus is in charge of global key account management and responsible for the market-oriented generation of product innovations. He holds a degree in Process Engineering from Technical University of Clausthal in Germany.

Mike is European Medicines Partnership Director for International Health Partners (www.ihpuk.org), a UK charity whose Queen’s Award for Enterprise and Innovation in 2011, recognises the tremendous humanitarian work sourcing donated medicines from the pharmaceutical industry and coordinating delivery via secure supply chain solutions to disaster-struck areas in close liaison with NGOs. Currently, Mike is working to expand the IHP network so that a European Access to Medicines platform can be developed to further harness the successful business model across a pan European landscape.

Mike also campaigns widely on the patient safety implications of counterfeit medicines and is the Executive Director of the European Alliance for Access to Safe Medicines (www.eaasm.eu). The EAASM is a pan-European patient safety organisation, bringing together all concerned with eliminating counterfeit medicines from the supply chain.

With patient safety at its heart, the EAASM is also currently championing positive change in the area of unlicensed/off-label usage of medicines which is severely compromising patients welfare and rights in certain medical conditions and situations.

Mike is also an Associate of the Ceuta Capability Group (www.ceutacapability.com) a consultancy that provides outsourced management expertise in healthcare.

Mike’s professional background is in pharmaceuticals, where he held senior management and director positions covering sales, marketing, commercial and supply chain in a 32 year career.

Anthony Dunnett is President of International Health Partners (IHP), a unique not-for-profit partnership with the global healthcare industry that aims to increase access to medicine and improve health in the developing world. As the charity’s founder, Anthony is responsible for the rapid growth of the enterprise and its strategic alliance with some of the world’s largest pharmaceutical manufacturers and leading international aid agencies. He came to the project with 25 years of experience in investment banking, ending as Finance Director of a number of HSBC’s businesses. He also spent 10 years working for the UK Government, overseeing inward investment into the UK. Since 2005, International Health Partners and its partners have provided over €100m of medical aid to underserved communities in 92 countries.

Anthony is currently focused on spearheading IHP’s flagship programme for the European pharmaceutical supply chain - the European Medicines Exchange (EME). The EME is a Europe-wide platform which is being established as the collaborative venture between Europe’s leading healthcare companies, medical NGOs, and academic institutions, to make better use of existing resources within the healthcare industry supply chain. In particular, it will target the appropriate and professional use of surplus inventory to build sustainable development in under-resourced health systems.